Please Wait...

Clinical Trial Articles

Whether you're interested in the current clinical trial management industry trends or want to know more about the latest FDA requirements, our collection of clinical trial articles will keep you up to date on what's happening now in clinical research news.

Clinical Trial Articles

2017

Essential ToolsCo-authored by Mélanie Bodnar-Wachtel, PhD and Tanja Schubert, PhD

This article is taken from European Biopharmaceutical Review April 2017, pages 34-38. © Samedan Ltd.

Three-Fold Solution

This article is taken from International Clinical Trials August 2017, pages 46-48. © Samedan Ltd

2016

Kristin Mauri, PMP, Enterprise Quality Management of Clinical Trials, April 2016.

Clare Jackson, Utku Ozdemir, Liz Moench.  Take a Chance.  ICT.  February 2016.

2014

Lin EH, Lenz HJ, Saleh MN, Mackenzie MJ, Knost JA, Pathiraja K, Langdon RB, Yao S, Lu BD.  A randomized, phase II study of the anti-insulin-like growth factor receptor type 1 (IGF-1R) monoclonal antibody robatumuma

Herron D. The New Road of Cardio-Oncology in Clinical Development. Applied Clinical Trials. April 1, 2014.

deVillafranca C, Andrus J. Technology Considerations To Increasing Clinical Trial Efficiencies With Risk-Based Monitoring. Life Science Leader. January 31, 2014.

2013

O'Neal M, Strafaci J, Scarimbolo R, and Van Heertum R. A Paradigm in Evolution. European Pharmaceutical Contractor (EPC) March 2013.

Borradaile K, Duffy K, O'Neal M. A Potential New Approach to Assessing PFS in Solid Tumor Studies. International Clinical Trials, May 2013.

2012

Yu HJ, Miller CG, Flitcraft D. Metrics in Medical Imaging: Changing the Picture. ACRP: The Monitor. August 2012.

2011

Spano Lander A and Lander, Reta C Rupich. No Limits: The Evolution of DXA. International Clinical Trials, February, 2011.

van Meurs P, Miller CG. Image Conscious: New FDA Guidance. Samedan Ltd. 2011 Dec: 24-28.

2010

Borradaile K, Robert F, O'Neal M, Byrne K.

Webber B.

Ahmad H.

2009

Weinstein M. An Albatross and an Opportunity. View on Clinical Operations. 2009 Jun.

2007

Claypool, B.  Functional outsourcing: a better alternative to traditional outsourcing and EDC. Next Generation Pharmaceutical. 2007.

2006

Reiber J, Heyrich G, van Weert A. A Period of Refinement. European Pharmaceutical Contractor (EPC). 2006;100-102.

2004

van Weert A, Reiber J.

van Weert A and Reiber J.

Kradjian S, Baratelle A, Einstein SG, Kaslow DCDevelopment of a Charter for an Endpoint Assessmen

Miller CG, Noever K.

2003

Miller C, Noever K. Scanning data for clinical information. Good Clinical Practices Journal. 2003. 10;9:21-24.

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Great advice from our Dir. Cardiovascular Imaging on how to achieve top quality imaging acquisitions & assessments… https://t.co/P57970FrOf
bioclinica (18 hours ago)
RT @CenterWatch: #CWWeekly: The increasing trend of adopting digital health and #mhealth apps for patient care. Read more, https://t.co/wo9…
bioclinica (19 hours ago)
RT @CenterWatch: Examining the difference between #patient engagement & patient recruitment. Read more in #CWPulse by @AshleyTointon, https…
bioclinica (19 hours ago)
RT @CenterWatch: How can #socialmedia play a role in health disparities and #clinicaltrial patient recruitment? Read more in #CWPulse by @A…
bioclinica (19 hours ago)
RT @RAPSorg: What New @FDAcdrhIndustry Guidance is Coming in FY 2018: Alternative 510(k) Pathway and More | #Regulatory Recon https://t.co/…
bioclinica (19 hours ago)
RT @RAPSorg: .@US_FDA Finalizes Guidance on Promotional Drug Labeling and Ads | #Regulatory Focus https://t.co/2rmtTWajlf #FDA #pharma
bioclinica (19 hours ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices